Erin Johanek, PharmD, RPh

Articles

Oncology Pipeline Predictions

October 08, 2018

This year has been another year full of oncology approvals, proving that the oncology pipeline is robust with first-of-the kind molecules, competitor products for existing agents, and biosimilars.